Investigational Medicine for COPD

This is a clinical trial of 24 weeks to evaluate the safety and effectiveness of an investigational medication to treat patients with COPD (emphysema or chronic bronchitis)

Ages 40-80
Must have a diagnosis of COPD
Are a current smoker or were a smoker in the past with at least a 10 pack-year exposure history

Study medication and all study related costs as well as a stipend will be
provided.

Share